Overall, the Tuttlingen-based KLS Martin Group is very satisfied with the course of the past financial year. The family-run medical technology company was able to generate worldwide sales of EUR 300 million for the first time in 2019. Worldwide sales growth was just under 10%, a very good growth rate in international comparison.
The USA, Germany, Saudi Arabia, China, Russia, Italy, Spain and Great Britain played a key role in overall growth in 2019. As in previous years, it is not only the classic growth markets that are represented among the growth drivers. The main growth driver was the US market. The inauguration of KLS Martin WORLD North America was celebrated there in October 2019. The new training center in Jacksonville hosts courses and workshops for doctors and OR staff.
"The current business development gives us a positive outlook for 2020, for which the KLS Martin Group is planning double-digit sales growth. To achieve this goal, we will create additional jobs at all locations, ”explains managing partner Christian Leibinger.
2020 will be an eventful year for the Swabian family company. The new production building "Building 70" is to be occupied in Mühlheim before the summer holidays. New space for the production and construction of implants and biomaterials is currently being created on around 5,300 m² on three levels. The building will be equipped with new production facilities and clean room technologies and will offer space for around 150 employees.
https://www.klsmartin.com/de/unternehmen/news/news-details/282-pressemitteilung-kls-martin-group-steigert-2019-den-weltweit- turnover-erneut-um-knapp-10/?cHash = 760a6018a4881d2fae5f5ad64cfbb4c7